Status:
UNKNOWN
ROX Index in Acute Respiratory Failure
Lead Sponsor:
Assiut University
Conditions:
Rox Index
Eligibility:
All Genders
18-60 years
Brief Summary
evaluation of ROX index among ICU patients to evaluate the success of non invasive ventilation or the need for intubation
Eligibility Criteria
Inclusion
- Participants admitted to RICU with type I and type II respiratory failure requiring NIV support with one or more of the following :
- PaO2/FiO2 less than or equal to 300 mmHg despite supplying oxygen at a flow rate ≥ to 10 l/min for ≥ 15 min
- Patients requiring ventilatory support due to increased respiratory rate ≥ 25 breaths/min or using accessory muscles of respiration
Exclusion
- 1\. Absolute indication for intubation like coma, hemodynamic instability, or life-threatening arrhythmia.
- 2\. Contraindication to NIV like untreated pneumothorax, pneumothorax with air leak, widespread facial burn or trauma, tracheotomy,or active upper gastrointestinal bleeding.
- 3\. Resusal to participate in the study
Key Trial Info
Start Date :
March 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05309239
Start Date
March 21 2022
End Date
March 1 2024
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt